CBR3 and digestive system disorder: In this study, we showed that in the arachidonic acid metabolic pathway, Cbr3 gene expression was downregulated in the gastric sinus tissue of the diabetic gastroenteropathy model group, indicating the presence of oxidative stress and abnormalities in endogenous chemical metabolism, as well as potential damage to critical proteins and metabolites.